On October 6, 2022, President Joe Biden announced pardons for people convicted to marijuana use and possession under federal law. He also announced that he was directing his administration to review marijuana’s listing as a Schedule I drug under the Controlled Substances Act, which is defined as one with a high potential for abuse, noContinue reading “Removing cannabis from Schedule I will make it possible to do long-needed research”
Category Archives: FDA
FDA and CDC release data highlighting FDA’s continuing failure to protect kids from ecigs
The FDA and CDC just published the first results from the 2022 National Youth Tobacco survey in the CDC’s MMWR. The 2022 survey shows that 1 in 4 youth use menthol e-cigs, further strengthening the case that FDA should end its de facto authorization of menthol e-cigs Specifically, 26.6% of kids say menthol is theirContinue reading “FDA and CDC release data highlighting FDA’s continuing failure to protect kids from ecigs”
DOJ urges Trump judge who has been sitting on FDA cigarette pack warning labels to act
A Trump judge in Texas has been sitting on a case the cigarette companies filed against the FDA’s mandated health warning labels for two years. By not acting, he has effectively blocked the labels nationally but, by not ruling, there has been nothing for the Justice Department to appeal. The DOJ filing (below) is finallyContinue reading “DOJ urges Trump judge who has been sitting on FDA cigarette pack warning labels to act”
Trump judge continues to delay cigarette warning labels by doing nothing
Last May a federal judge in Texas appointed by President Trump again delayed ruling on the tobacco companies’ lawsuit against the Congressionally-mandated warnings on cigarette packs that the FDA finally issued in 2020. Now he has done it again, pushing the rule’s effective date for the warning labels by an additional 90 days, to OctoberContinue reading “Trump judge continues to delay cigarette warning labels by doing nothing”
Massachusetts’ comprehensive flavor ban cut menthol sales by 96% and overall tobacco sales by 25%
While the FDA continues to dither on getting rid of flavored tobacco products, most notably menthol e-cigarettes, states and localities continue to move forward. The tobacco companies continue to argue that such bans don’t work and that people will just switch to other products. Melody Kingsley, Hannah McGinnes, and their colleagues at the Massachusetts DepartmentContinue reading “Massachusetts’ comprehensive flavor ban cut menthol sales by 96% and overall tobacco sales by 25%”
Another way FDA is cutting ecig companies slack: shelf life
E-cigarettes have finite shelf lives because they become more toxic over time while they sit on the shelf. E-cigarettes are often contaminated with bacteria and fungus that grow while the e-cigarettes sit on the shelf. In addition, the chemicals in the e-liquid continue reacting with each other after they are mixed, growing more toxic overContinue reading “Another way FDA is cutting ecig companies slack: shelf life”
Juul knows why FDA denied its request to legally sell its ecigs. Why won’t FDA tell the rest of us?
On June 23, 2022, FDA denied Juul’s application for authorization to sell its e-cigarettes in the USA. While FDA quickly backed down and allowed Juul to remain on the market while the FDA considered “scientific issues unique to the JUUL application that warrant additional review,” there is a lot of interest in FDA’s reasoning forContinue reading “Juul knows why FDA denied its request to legally sell its ecigs. Why won’t FDA tell the rest of us?”
FDA was correct in not quantifying consumer surplus in its analysis of the proposed standard for menthol in cigarettes
My colleagues at UCSF and other universities and I have submitted this comment to the FDA in response to its proposal to prohibit the use of menthol in cigarettes. A PDF of the comment is here. The Regulations.gov tracking number is l6b-h3rv-v16n. FDA was correct in not quantifying consumer surplus in its analysis of theContinue reading “FDA was correct in not quantifying consumer surplus in its analysis of the proposed standard for menthol in cigarettes”
FDA’s economic model underestimates the benefits of the proposed product standard prohibiting menthol in cigarettes, so the benefits would be even greater
My colleagues at UCSF and other universities and I have submitted this comment to the FDA in response to its proposal to prohibit the use of menthol in cigarettes. A PDF of the comment is here. The Regulations.gov tracking number is l6b-gxso-b6yq. FDA’s economic model underestimates the benefits of the proposed product standard prohibiting mentholContinue reading “FDA’s economic model underestimates the benefits of the proposed product standard prohibiting menthol in cigarettes, so the benefits would be even greater”
FDA should extend the scope of its proposed cigar flavor standard to prohibit flavors in all tobacco products, including e-cigarettes and smokeless tobacco, to make them less appealing to adolescents and young adults
My colleagues at the UCSF TCORS and I submitted this public comment to the FDA on its proposal to remove flavors from cigars. A PDF of the comment is here. The Regulations.gov tracking number is l6c-lwj1-vcu7. FDA should extend the scope of the proposed flavor standard to prohibit flavors in all tobacco products, including e-cigarettesContinue reading “FDA should extend the scope of its proposed cigar flavor standard to prohibit flavors in all tobacco products, including e-cigarettes and smokeless tobacco, to make them less appealing to adolescents and young adults”
Stanton Glantz blog 